Onset Dermatologics, a PreCision Dermatology company and a leader in developing and commercializing novel, prescription products for improving skin health, today announced the launch of HylatopicPlus™ Cream. HylatopicPlus™ Cream is indicated to manage and relieve the burning, itching and pain experienced with various types of skin conditions, including atopic dermatitis (eczema), allergic contact dermatitis and radiation dermatitis. HylatopicPlus™ Cream also helps alleviate dry, waxy skin by maintaining a moist wound and skin environment, which is beneficial to the healing process.
In recently published comments, Archbold Memorial Hospital announced it has become the first in the state of Georgia, "to revolutionize surgical treatment for lung cancer using mesh brachytherapy and the da Vinci Robot." General and thoracic surgeon Edward Hall, MD, and radiation oncologist Steven Johnson, MD, of Archbold’s Lewis Hall Singletary Oncology Center performed the surgery on a 64-year old female patient. To hear more about the doctors' experience and what the patient has to say, follow this link. http://www.walb.com/story/15238595/new-procedure-mayHylatopicPlus™ is contraindicated in persons with a known hypersensitivity to any of the components of the formulation. If clinical signs of infection are present, appropriate treatment should be initiated; use of HylatopicPlus Cream may be continued during the anti-infective therapy."HylatopicPlus™ Cream is an important addition to our product line as we continue to develop innovative skincare therapies that are elegant, effective and economical," noted Jeffrey Wayne, Senior Vice President and General Manager, Onset Dermatologics. "The addition of HylatopicPlus™ Cream provides an alternative delivery vehicle for patients and healthcare providers that we believe will increase patient compliance in adhering to prescribed treatment regimens for atopic dermatitis. We have been extremely pleased with the rapid adoption of HylatopicPlus™ Emollient Foam, which has become the number-one, fastest-growing barrier relief therapy in 2011 and have confidence that HylatopicPlus™ Cream will have similar success in the market."About PreCision Dermatology, Inc.Universal Detection Technology Email ContactAbout IsoRay, Inc.About Universal Detection TechnologyHylatopicPlus™ Cream is formulated to rapidly hydrate the stratum corneum and provide a semi-permeable barrier that protects against irritants and excessive water loss through the skin. HylatopicPlus™ incorporates hyaluronic acid to deliver a blend of physiologic lipids, including ceramide, to restore healthy barrier function. HylatopicPlus™ has been clinically proven to improve the symptoms of atopic dermatitis.For more product information please email sales@udetection.com .Onset Dermatologics ( www.onsetdermatologics.com ) is dedicated to providing new, optimized, innovative, practical and cost-effective pharmaceutical products to the healthcare market in an effort to improve the quality of life for patients. The company markets 11 products based on its proprietary Delevo® foam technology platform that is designed to deliver enhanced penetration of proven active ingredients while improving patient compliance.The Company's second quarter revenues increased 2,675% to $30,508 from $1,099 during second quarter 2010. The Company is also announcing that based on current backlog and recently shipped devices, third quarter 2011 revenues are on pace to surpass the second quarter revenues.IsoRay CEO Dwight Babcock says the combination of da Vinci robotics and his company's Cesium-131 mesh brachytherapy is proving a winning combination,"We are hearing from a number of physicians and medical facilities, who are looking at applications to treat a variety of cancers throughout the body. We are confident that this interest and excitement will translate into important benefits for patients who are fighting the toughest battles of their lives. This is about cancer control and survival and it comes with improved quality of life. I continue to believe that it's the insurance policy no patient can afford to be without. "(2) Shaw TE, Currie GP, Koudelka CW, Simpson EL. Eczema Prevalence in the United States: Data from the 2003 National Survey of Children's Health. J Invest Dermatol. 2011;131(1):67-73.Dr. Del Rosso explained that the top layer of the skin is involved in several protective functions and can be affected by skin conditions such as eczema, acne or their treatments, in some cases.According to radiation oncologist Johnson, “With mesh brachytherapy, patients benefit from getting the most targeted radiation possible, which decreases the chance of the cancer recurring and decreases the amount of potential lung damage...placing Cesium (131), a radioactive chemical element used for treating cancer, over the suture line reduces the risk of cancer recurrence in patients to 10 percent or less,” said Johnson.For Further Information: Erich Sandoval Lazar Partners, LTD (805) 667-8402 esandoval@lazarpartners.com Rachel Kessler Lazar Partners, LTD (212) 867-1762 rkessler@lazarpartners.com(1) PubMed Health. http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001856/ . Accessed August 19, 2011.
For Further Information: Erich Sandoval Lazar Partners, LTD (805) 667-8402 esandoval@lazarpartners.com Rachel Kessler Lazar Partners, LTD (212) 867-1762 rkessler@lazarpartners.com
No comments:
Post a Comment